Ratios from the company's XBRL filings, latest filings
Revenue, TTM
n/a
the filed year and its quarters do not reconcile, so the trailing figure is withheld
Revenue, TTM BLMH
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
Sep 2025
$4.8M
Jun 2025
$3.5M
Mar 2025
$2.2M
Dec 2024
$3.1M
Sep 2024
$4.4M
Jun 2024
$3.8M
Mar 2024
$6.8M
Dec 2023
$6.6M
At each fiscal year end
Single quarter
Net margin, TTM
n/a
the filed year and its quarters do not reconcile, so the trailing figure is withheld
Net margin, TTM BLMH
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
Sep 2025
-52.8%
Jun 2025
-54.3%
Mar 2025
-25.2%
Dec 2024
+511.9%
Sep 2024
-76.6%
Jun 2024
+628.3%
Mar 2024
-45.0%
Dec 2023
-120.5%
At each fiscal year end
Single quarter
Free cash flow, TTM
-$1.8M
operating cash flow minus capex, 2024-10-01 to 2025-09-30
Free cash flow, TTM BLMH
FY Dec 2024
-$1.6M
FY Dec 2023
-$1.3M
FY Dec 2022
n/a
Sep 2025
-$683.0K
Jun 2025
-$496.0K
Mar 2025
-$364.0K
Dec 2024
-$243.0K
Sep 2024
-$460.0K
Jun 2024
-$91.0K
Mar 2024
-$765.0K
Dec 2023
-$687.0K
At each fiscal year end
Single quarter
Debt to equity
n/a
equity is zero or negative, the ratio has no meaning
Debt to equity BLMH
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
Jun 2024
n/a
Mar 2024
n/a
Dec 2023
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
-0.34x
TTM operating cash flow over long-term 2025-09-30 plus current 2025-09-30
Cash flow to debt BLMH
FY Dec 2024
-0.52x
FY Dec 2023
-0.03x
FY Dec 2022
n/a
Sep 2025
-0.34x
Jun 2025
-0.32x
Mar 2025
-0.38x
Dec 2024
-0.52x
Sep 2024
-0.20x
Jun 2024
-0.06x
Mar 2024
0.02x
Dec 2023
-0.03x
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
n/a
average equity is zero or negative
Return on equity BLMH
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
Jun 2024
n/a
Mar 2024
n/a
Dec 2023
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+25.4%
TTM net income over average of 2024-09-30 and 2025-09-30
Return on assets BLMH
FY Dec 2024
+116.4%
FY Dec 2023
-38.9%
FY Dec 2022
n/a
Sep 2025
+25.4%
Jun 2025
+25.4%
Mar 2025
+127.7%
Dec 2024
+116.4%
Sep 2024
+25.3%
Jun 2024
+24.8%
Mar 2024
-49.3%
Dec 2023
-38.9%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
invested capital is zero or negative
Return on invested capital BLMH
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
Jun 2024
n/a
Mar 2024
n/a
Dec 2023
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
+433.7%
operating income (EBIT proxy) over average of 2024-09-30 and 2025-09-30 minus current liabilities
Return on capital employed BLMH
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
Sep 2025
+433.7%
Jun 2025
+490.5%
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
Jun 2024
n/a
Mar 2024
n/a
Dec 2023
n/a
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
n/a
fewer than four consecutive quarters of diluted EPS
P/E, trailing BLMH
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
Jun 2024
n/a
Mar 2024
n/a
Dec 2023
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$8.5M
market value at close 2026-10-27 on 2025-11-13 shares, plus long-term 2025-09-30 plus current 2025-09-30, minus cash 2025-09-30
Enterprise value BLMH
FY Dec 2024
$6.3M
FY Dec 2023
n/a
FY Dec 2022
n/a
Sep 2025
$14.0M
Jun 2025
$13.9M
Mar 2025
$15.3M
Dec 2024
$6.3M
Sep 2024
$12.3M
Jun 2024
$12.7M
Mar 2024
n/a
Dec 2023
n/a
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
-47.2%
TTM free cash flow over market value at close 2026-10-27
FCF yield BLMH
FY Dec 2024
-35.6%
FY Dec 2023
n/a
FY Dec 2022
n/a
Sep 2025
-19.4%
Jun 2025
-16.5%
Mar 2025
-9.2%
Dec 2024
-35.6%
Sep 2024
-48.9%
Jun 2024
-17.3%
Mar 2024
n/a
Dec 2023
n/a
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
fewer than four consecutive quarters of diluted EPS
PEG, trailing BLMH
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
Jun 2024
n/a
Mar 2024
n/a
Dec 2023
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-27. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
BLMH ranks highest on profitability (98th percentile) and growth (93rd), and lowest on financial health (12th), among Wholesale & Retail peers.
Profitability
98
Inputs
Return on equityaverage equity is zero or negative
Return on assets+25.4% · 97 pct, sector of 257
Return on invested capitalinvested capital is zero or negative
Return on capital employed+433.7% · 100 pct, sector of 220
Financial health
12
Inputs
Debt to equityequity is zero or negative, the ratio has no meaning
Cash flow to debt-0.34x · 12 pct, sector of 210
Growth
93
Inputs
Revenue growth, YoY+67.5% · 93 pct, sector of 311
Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Risk and compliance
93
Inputs
Short interest, % of float+0.0% · 93 pct, sector of 317
Recalls per $1B revenue, 3yrevenue under $50M or not filed, so a count cannot be scaled to size
EPA cases per $1B revenue, 5yrevenue under $50M or not filed, so a count cannot be scaled to size
New text in Risk Factors, latest 10-Kneeds two 10-Ks with a Risk Factors section (not 20-F filers or stubs)
3 not measured: Insider conviction, Institutional and government, US patents
Insider conviction needs 1 of 2 inputs, 0 present: no Form 4 purchase or sale (code P or S) in 180 days; no insider trades in 180 days
Institutional and government needs 1 of 4 inputs, 0 present: fewer than five funds report holding it; no Congress trades in 365 days; no federal contracts in 180 days; no lobbying filings in the last four quarters
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
4 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.